Trabeculectomy With Mitomycin C in Secondary Glaucoma Associated With Behçet Disease

Abstract

Trabeculectomy with MMC provides reduction of IOP and the number of antiglaucoma medications in cases with secondary glaucoma associated with BD in a 1-year follow-up period.

Ahmed Glaucoma Valve Implantation for Uveitic Glaucoma Secondary to Behçet Disease

“…Yalvac et al 12 achieved overall 1-, 2-, 3-, 4-, and 5-year success rates of 83%, 76%, 70%, 66%, and 62%, respectively, in 26 eyes treated with trabeculectomy and MMC. Almost same success rate with BD, 82%, was achieved for the first year of trabeculectomy and MMC by Elgin et al 14 Similar results have been reported for nonselective uveitic 16 with success rates of 70% at 34 months and 50% at 5 years, respectively. Late failure rates are higher than those reported for trabeculectomy in patients with nonuveitic glaucoma.…”

Deep sclerectomy for uveitic glaucoma: long-term outcomes

“…5,6 Despite this it remains a common first line surgical procedure in these cases, particularly when augmented with Mitomycin C (MMC) or 5-Fluorouracil (5-FU). [6][7][8][9][10][11][12] This may reflect the widespread choice of trabeculectomy as the preferred primary procedure by many glaucoma surgeons, which still leaves the option of subsequent glaucoma drainage implantation (GDI) if necessary. There are increasing numbers of reports in the literature regarding the use and efficacy of GDI for UG with some authors suggesting this as a primary procedure in all cases with a high failure risk.…”

Deep Sclerectomy with Mitomycin C for Glaucoma Secondary to Uveitis

“…The surgical procedure of choice is probably trabeculectomy with mitomycin C (MMC) as evidenced by a number of recent reports (6)(7)(8)(9)(10)(11). This is perhaps because it is the preferred procedure for primary glaucoma for most ophthalmic surgeons.…”